Xiangsong Wu
- Cancer Research top 2%
- Cancer-related molecular mechanisms research 16
- MicroRNA in disease regulation 8
- Molecular Biology top 5%
- RNA modifications and cancer 10
- Cell death mechanisms and regulation 8
- Oncology top 5%
- Pancreatic and Hepatic Oncology Research 6
- Toxicology top 5%
- Pharmacology top 5%
-
- Cholangiocarcinoma and Gallbladder Cancer Studies 25
-
- Gastric Cancer Management and Outcomes 6
-
- Cancer Mechanisms and Therapy 6
- Partner nations
- ChinaUnited StatesIndia
In The Last Decade
Xiangsong Wu
74 papers receiving 2.5k citations
Peers
Comparison fields: 5 of 105
- Cancer Research 914
- Molecular Biology 1.6k
- Oncology 568
- Toxicology 55
- Pharmacology 140
Countries citing papers authored by Xiangsong Wu
This map shows the geographic impact of Xiangsong Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiangsong Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiangsong Wu more than expected).
Fields of papers citing papers by Xiangsong Wu
This network shows the impact of papers produced by Xiangsong Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiangsong Wu. The network helps show where Xiangsong Wu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xiangsong Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 11 | |
| 2 | 2022 | 14 | |
| 3 | 2020 | 12 | |
| 4 | 2020 | 12 | |
| 5 | 2020 | 24 | |
| 6 | 2019 | 141 | |
| 7 | 2019 | 3 | |
| 8 | 2018 | 19 | |
| 9 | 2018 | 86 | |
| 10 | 2017 | 72 | |
| 11 | 2017 | 41 | |
| 12 | 2015 | 27 | |
| 13 | The update strategy of the isolated caudate lobe resection:A report of 21 cases | 2014 | 1 |
| 14 | 2014 | 59 | |
| 15 | 2014 | 77 | |
| 16 | 2014 | 29 | |
| 17 | [Differential gene expression profiles of gastric cancer]. | 2012 | 1 |
| 18 | 2012 | 13 | |
| 19 | 2012 | 46 | |
| 20 | 2008 | 5 |
About Xiangsong Wu
Xiangsong Wu is a scholar working on Cancer Research, Oncology and Surgery, having authored 74 papers that have together received 2.5k indexed citations. Recurring topics across this work include Cholangiocarcinoma and Gallbladder Cancer Studies (25 papers), Cancer-related molecular mechanisms research (16 papers), RNA modifications and cancer (10 papers), MicroRNA in disease regulation (8 papers), Cell death mechanisms and regulation (8 papers), Pancreatic and Hepatic Oncology Research (6 papers), Gastric Cancer Management and Outcomes (6 papers) and Cancer Mechanisms and Therapy (6 papers). The work is most often cited by research in Cancer Research (914 citations), Molecular Biology (1.6k citations) and Oncology (568 citations). Xiangsong Wu has collaborated with scholars based in China, United States and India. Frequent co-authors include Yingbin Liu, Maolan Li, Jiasheng Mu, Yang Cao, Hao Weng, Runfa Bao, Yijun Shu, Wenguang Wu, Yunping Hu and Zhujun Tan. Their work appears in journals such as Cell Death and Differentiation, Molecules and Gene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.